Download Guideline

Guideline (PDF)

Child Psychotherapeutic Medication Guidelines Cover

Nicholas Abid, DO, MBA, FACN – Sunshine Health

Regina Bussing, MD, MSHS, DFAPA, DFAACAP (Speaker) – University of Florida

Daniel Castellanos, MD (Speaker) – FIU Herbert Wertheim College of Medicine

Christoph U. Correll, MD (Speaker) – Zucker School of Medicine at Hofstra/Northwell

Manal Durgin, MD, DFAPA – Devereux Florida

Karen A. Goldberg, MD, CHCQM, DFAACAP – Kepro

Anthony F. Gomes, MD – BayCare Medical Group

Licet Martell, PharmD, BCGP – Sunshine Health

Jon McClellan, MD (Speaker) – University of Washington

Kishan Nallapula, MD – University of Florida

Emilio Roig, MD – Devereux Florida

Eugenio M. Rothe, MD, DLFAPA, DFAACAP, PsAAPDP (Speaker) – FIU Herbert Wertheim College of Medicine

Leigh J. Ruth, MD – University of South Florida

Bhagirathy Sahasranaman, MD, DLFAPA, DFAACAP – Sunshine Health

Vanita Sahasranaman, MD – Henderson Behavioral Health

Michael A Shapiro, MD – University of Florida

Saundra Stock, MD (Speaker) – University of South Florida

Kimberly Sundling, PharmD, BCPP – Florida Blue

Conversation

2022 – 2023 Florida Best Practice Psychotherapeutic Medication Guidelines for Children and Adolescents

Video Presentations

2022 Attention Deficit Hyperactivity Disorder (ADHD) Guideline Update (Regina Bussing, MD, MSHS)

Major Depressive Disorder in Children & Adolescents (Daniel Castellanos, MD)

Early-Onset Schizophrenia (Christoph U. Correll, MD)

Chronic Impulsive Aggression (Jon McClellan, MD)

Treatment Pediatric Non-OCD Anxiety Disorders: Update 2022 (Saundra Stock, MD)

Post-Traumatic Stress Disorder (PTSD) in the Time of COVID (Eugenio M. Rothe, MD)

Bipolar Disorder (Jon McClellan, MD)

Treatment of Pediatric OCD in Kids: Update 2022 (Saundra Stock, MD)

Summary Download

Summaries Downloads

2022-2023 CA GL_Deprescribing

Florida Program for Behavioral Health
Improvements and Solutions

Conversation